AVIR Annual Accounts Payable
$4.25 M
+$1.70 M+66.68%
31 December 2023
Summary:
As of January 23, 2025, AVIR annual accounts payable is $4.25 million, with the most recent change of +$1.70 million (+66.68%) on December 31, 2023. During the last 3 years, it has risen by +$4.19 million (+6986.67%). AVIR annual accounts payable is now -6.22% below its all-time high of $4.53 million, reached on December 31, 2021.AVIR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVIR Quarterly Accounts Payable
$5.79 M
+$315.00 K+5.76%
30 September 2024
Summary:
As of January 23, 2025, AVIR quarterly accounts payable is $5.79 million, with the most recent change of +$315.00 thousand (+5.76%) on September 30, 2024. Over the past year, it has increased by +$5.39 million (+1364.56%). AVIR quarterly accounts payable is now -73.93% below its all-time high of $22.19 million, reached on September 30, 2021.AVIR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVIR Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +66.7% | +1364.6% |
| 3 y3 years | +6986.7% | +1364.6% |
| 5 y5 years | +987.5% | +1364.6% |
AVIR Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.2% | +66.7% | -72.6% | +1364.6% |
| 5 y | 5-year | -6.2% | +6986.7% | -73.9% | +9541.7% |
| alltime | all time | -6.2% | +6986.7% | -73.9% | +9541.7% |
Atea Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $5.79 M(+5.8%) |
| June 2024 | - | $5.47 M(-74.1%) |
| Mar 2024 | - | $21.14 M(+397.1%) |
| Dec 2023 | $4.25 M(+66.7%) | $4.25 M(+976.5%) |
| Sept 2023 | - | $395.00 K(-90.0%) |
| June 2023 | - | $3.96 M(+466.0%) |
| Mar 2023 | - | $700.00 K(-72.6%) |
| Dec 2022 | $2.55 M | $2.55 M(+128.2%) |
| Sept 2022 | - | $1.12 M(-91.9%) |
| June 2022 | - | $13.88 M(+279.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.66 M(-19.3%) |
| Dec 2021 | $4.53 M(+7456.7%) | $4.53 M(-79.6%) |
| Sept 2021 | - | $22.19 M(+107.4%) |
| June 2021 | - | $10.70 M(+182.2%) |
| Mar 2021 | - | $3.79 M(+6220.0%) |
| Dec 2020 | $60.00 K(-89.1%) | $60.00 K(-98.7%) |
| Sept 2020 | - | $4.48 M(+16.0%) |
| June 2020 | - | $3.86 M(+604.4%) |
| Dec 2019 | $548.00 K(+40.2%) | $548.00 K |
| Dec 2018 | $391.00 K | - |
FAQ
- What is Atea Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual accounts payable year-on-year change?
- What is Atea Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly accounts payable year-on-year change?
What is Atea Pharmaceuticals annual accounts payable?
The current annual accounts payable of AVIR is $4.25 M
What is the all time high annual accounts payable for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual accounts payable is $4.53 M
What is Atea Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AVIR annual accounts payable has changed by +$1.70 M (+66.68%)
What is Atea Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AVIR is $5.79 M
What is the all time high quarterly accounts payable for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly accounts payable is $22.19 M
What is Atea Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AVIR quarterly accounts payable has changed by +$5.39 M (+1364.56%)